Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
about
Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.Emollients and moisturisers for eczema: abridged Cochrane systematic review including GRADE assessments.Severity assessments used for inclusion criteria and baseline severity evaluation in atopic dermatitis clinical trials: a systematic review.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Burden of skin pain in atopic dermatitis.Severity strata for five patient-reported outcomes in adults with atopic dermatitis.Validation of patient-reported global severity of atopic dermatitis in adults.Relationship between EASI and SCORAD severity assessments for atopic dermatitis.Increased attention-deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use.Clinical bandings of Patient-Oriented Eczema Measure scores among Japanese patients with atopic eczema.Finding a HOME for outcome measures in atopic dermatitis.Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness.Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
P2860
Q33922867-3076F2B4-30C7-4C35-94A5-3EBBC401D479Q36354045-2FB6635B-E500-476C-B226-A26EE4C0B75EQ38657405-47157FC2-19A2-4E2A-BFC1-6E02313F0712Q47260366-F7081742-DF44-4121-8BC2-185814990D63Q47548008-9E64153E-5711-413D-BFB4-3584B7338D20Q47648908-63C90D15-268A-465E-8C96-0CA176AD3C49Q47695337-3291BCCE-328D-4606-8E71-D154AF167774Q47818073-348B7E4C-5AB4-459C-9A21-5F1EB435DB50Q48248349-BA096F94-7F22-45C1-B2F6-47599F1D02CEQ48249134-34C674E5-8740-425F-918F-5F076F9BA410Q48266375-8E991CBD-DD52-4D67-8E93-71FAC12A68C7Q55362713-2742B8A9-43A6-4E09-B84D-444107B74675Q58694533-CAA2E91E-5F31-4E2F-BCAC-4996B56DB9D3
P2860
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patient-Oriented Eczema Measur ...... s for Eczema (HOME) statement.
@en
type
label
Patient-Oriented Eczema Measur ...... s for Eczema (HOME) statement.
@en
prefLabel
Patient-Oriented Eczema Measur ...... s for Eczema (HOME) statement.
@en
P2093
P2860
P50
P356
P1476
Patient-Oriented Eczema Measur ...... es for Eczema (HOME) statement
@en
P2093
C A C Prinsen
H C Williams
HOME initiative collaborators
J R Chalmers
L B von Kobyletzki
P2860
P304
P356
10.1111/BJD.15179
P407
P577
2017-03-02T00:00:00Z